Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 585 of 6351
-
New drug combo targets tough blood cancers
Disease control Recruiting nowTo learn about the safety and tolerability of study drug combinations in patients with relapsed/refractory, IDH1-mutated myeloid malignancies with a co-signaling mutation.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Heart transplant patients may get safer virus protection
Disease control Recruiting nowThe purpose of this study is to compare the safety and efficacy of letermovir with valganciclovir for prevention of Cytomegalovirus (CMV) viremia in moderate to high risk serostatus heart transplant recipients.
Phase 2/3 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for hard-to-treat blood cancer: combo therapy trial launches
Disease control Recruiting nowThe purpose of the study is to compare the efficacy of QLS32105 (SC) in combination with Pomalidomide, and QLS32105 (SC) in combination with QL2109 or Daratumumab, and QLS32105 (SC) in combination with QL2109 or Daratumumab and Pomalidomide, and QLS32105(SC) in combination with B…
Phase 2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a simple supplement slow Alzheimer's? new trial aims to find out
Disease control Recruiting nowThis randomised, double-blinded, placebo-controlled study aims to establish metabolic improvements in subjects diagnosed with Alzheimer's Disease (AD) by treatment with CMA2 including N-acetyl-L-cysteine (NAC), L-carnitine-L-tartrate (LCAT), nicotinamide (niacinamide), and L-seri…
Phase 3 • Sponsor: ScandiBio Therapeutics AB • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New cocktail targets lung cancer brain metastases
Disease control Recruiting nowThis is a Phase II, single-arm, multicenter trial for patients with metastatic non-small cell lung cancer who have brain metastases and no known actionable mutations. Eligible patients will receive a combination of Datopotamab-deruxtecan, Carboplatin, and Pembrolizumab every thre…
Phase 2 • Sponsor: Latin American Cooperative Oncology Group • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New chemo combo aims to boost survival in tough esophageal cancer
Disease control Recruiting nowBoth neoadjuvant chemoradiotherapy (CROSS) and neoadjuvant chemotherapy (FLOT) have demonstrated overall survival benefit over surgery alone in esophageal and esophagogastric junction (EGJ) cancer. Despite these survival gains, the prognosis remains poor, especially in patients w…
Phase 2 • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New combo therapy aims to shrink rectal tumors before surgery
Disease control Recruiting nowThis is a multicenter, cohort, prospective study to evaluate the efficacy and safety of Adebrelimab combined with radiotherapy and chemotherapy as preoperative neoadjuvant therapy for patients with locally advanced rectal cancer. In the study, all subjects who meet the inclusion …
Phase 2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can a lotion outperform standard gel for knee pain?
Symptom relief OngoingThis is a Phase II clinical trial designed to evaluate the efficacy and safety of ASKC200 Lotion in patients with knee osteoarthritis (KOA) pain. A total of 175 eligible patients will be randomly assigned to three groups at a 1:2:2:2 ratio: the experimental group1 (treated with 1…
Phase 2 • Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
New combo therapy aims to control advanced prostate cancer
Disease control OngoingThe purpose of this study is to assess safety of combination of AAA617 (administered for 6 cycles at a dose of 7.4 GBq (200 mCi) +/- 10%) and ARPI and AAA617 alone in PSMA-positive mCRPC patients who were previously treated and progressed on ARPI in the biochemical recurrence (BC…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New 24-Strain pneumonia vaccine trial launches for kids
Vaccine CompletedThe Phase II clinical trial of the 24-valent pneumococcal polysaccharide conjugate vaccine (RZ700) will be carried out in infants and young children aged 2 months (minimum 6 weeks) to 71 months. The purpose of this study is to evaluate the immunogenicity and safety of the 24-vale…
Phase 2 • Sponsor: Reinovax Biologics Co., LTD • Aim: Vaccine
Last updated Jul 29, 2026 00:00 UTC
-
Personalized mRNA vaccine shows promise for biliary cancer patients
Disease control Recruiting nowThe primary objective of this study is to evaluate the safety of iNeo-Vac-R01, an individualized mRNA therapeutic technology based on tumor neoantigens, for the adjuvant treatment of patients with biliary malignant tumors after radical resection.
Phase 1/2 • Sponsor: Yifan Wang • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New combo attack on sarcoma aims to delay return of cancer
Disease control Recruiting nowThe goal of this clinical research study is to look at the effectiveness of giving a combination of chemotherapy, immunotherapy, radiation therapy, and surgery to treat soft tissue sarcomas that can be removed by surgery. Researchers want to find out if this treatment combination…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New gel could ease blistering for skin disorder patients
Disease control Recruiting nowThis Phase II clinical study will assess the efficacy, safety and tolerability of topical TolaSure Gel in adults and pediatric patients (2 years of age and older) diagnosed with localized, intermediate, or severe epidermolysis bullosa simplex (EBS). Each patient (40 to complete) …
Phase 2 • Sponsor: BioMendics, LLC • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can the MMR vaccine protect transplant kids? new study seeks answers
Prevention Recruiting nowThe study is an interventional, non-randomized assessment of safety and efficacy of live Measles, Mumps and Rubella (MMR) vaccine in subjects aged 12-months to 17 years who have undergone heart transplantation. Subjects who provide permission/assent will receive the commercial MM…
Phase 4 • Sponsor: Children's Mercy Hospital Kansas City • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Could plyometric and core exercises make runners faster and Injury-Free?
Prevention PausedStudy aim was to evaluate effectiveness of two home-based exercise programs upon athletic performance, physical parameters and injury reduction in recreational runners. Participants were randomized to multicomponent and traditional strength exercise program in block randomization…
Sponsor: Yeditepe University • Aim: Prevention
Last updated Aug 05, 2026 00:00 UTC
-
Head-to-Head: which drug works best for stubborn Crohn's?
Disease control Not yet recruitingCrohn's disease is a chronic inflammatory bowel disorder characterized primarily by abdominal pain and diarrhea \[1,2\]. Conventional treatments include corticosteroids and immunosuppressants (such as azathioprine, mercaptopurine, and methotrexate) \[2,3\]. The introduction of an…
Phase 3 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 26, 2026 13:11 UTC
-
New combo therapy aims to keep advanced breast cancer in check longer
Disease control Not yet recruitingThis is a phase II trial exploring the maintenance therapy with trastuzumab combined with pyrotinib or dalpiciclib and endocrine therapy in HER2-positive advanced breast cancer based on different hormone receptor (HR) statuses following trastuzumab rezetecan (T-DXh, SHR-A1811) as…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 26, 2026 18:20 UTC
-
New H5N8 bird flu vaccine enters human trials
Vaccine Recruiting nowThis study aims to demonstrate the safety and immunogenicity of two formulations of the monovalent influenza vaccine candidate A (H5N8) (inactivated, fragmented, and adjuvanted with IB160) from the Instituto Butantan in adults and older adults, to be developed for situations of p…
Phase 1/2 • Sponsor: Butantan Institute • Aim: Vaccine
Last updated Jun 27, 2026 12:03 UTC
-
New combo therapy targets hard-to-treat sarcoma
Disease control Recruiting nowA phase 2 study assessing the efficacy of all-trans retinoic acid (ATRA) and Cemiplimab in patients with metastatic/locally advanced - unresectable leiomyosarcoma (LMS) who have progressed standard-of-care therapy. Patients will be enrolled in cohorts according to a Bayesian Opti…
Phase 2 • Sponsor: Gabriel Tinoco • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could MDMA help treat OCD? new study investigates
Symptom relief Recruiting nowThe study assesses the safety and preliminary effectiveness of MDMA-assisted cognitive behavioral therapy in participants diagnosed with obsessive-compulsive disorder (OCD).
Phase 2 • Sponsor: Carolyn Rodriguez • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC